Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
treatment entities : Novo nordisk a::S save search
Awiqli® (once-weekly basal insulin icodec) recommended for approval for the treatment of diabetes by the European regulatory authorities
Published: 2024-03-21 (Crawled : 16:00) - globenewswire.com
NVO | News | $124.53 0.88% 0.0% 2.6M
|
Health Technology
|
| O: -1.04%
H: 1.6%
C: 0.64%
awiqli approval treatment diabetes insulin
FDA Approves First Treatment to Reduce Risk of Serious Heart Problems Specifically in Adults with Obesity or Overweight
Published: 2024-03-08 (Crawled : 20:00) - prnewswire.com
NVO | News | $124.53 0.88% 0.0% 2.6M
|
Health Technology
| Email alert
Add to watchlist
fda obesity first treatment risk heart
COMBINE 3 phase 3a trial successfully completed with once-weekly IcoSema demonstrating non-inferior reduction in HbA1c versus daily basal-bolus treatment (insulin glargine U100 and insulin aspart) in people with type 2 diabetes
Published: 2024-01-08 (Crawled : 13:00) - globenewswire.com
NVO | News | $124.53 0.88% 0.0% 2.6M
|
Health Technology
|
| O: 0.19%
H: 0.34%
C: 0.21%
treatment glargine trial diabetes insulin
Novo Nordisk enters into research collaborations with Omega Therapeutics and Cellarity on novel treatment approaches for cardiometabolic diseases
Published: 2024-01-04 (Crawled : 11:00) - globenewswire.com
OMGA | $2.565 6.43% 6.04% 390K
|
|
| O: 92.31%
H: 20.0%
C: 1.24%
NVO | News | $124.53 0.88% 0.0% 2.6M
|
Health Technology
|
| O: 1.44%
H: 3.68%
C: 2.4%
treatment research therapeutics
Nalu Medical, Inc. Announces $65 Million Equity Financing to Advance Treatment for Chronic Neuropathic Pain
Published: 2024-01-03 (Crawled : 17:00) - biospace.com/
NVO | News | $124.53 0.88% 0.0% 2.6M
|
Health Technology
|
| O: -0.06%
H: 1.75%
C: 1.54%
million treatment
Global Bleeding Disorders Treatment Market Surpasses $14 Billion in 2022, Expected to Reach $20.3 Billion by 2028
Published: 2023-10-25 (Crawled : 22:00) - prnewswire.com
TAK | $13.15 -0.61% 0.0% 1.6M
|
Health Technology
|
| O: -4.69%
H: 0.69%
C: -3.18%
NVO | News | $124.53 0.88% 0.0% 2.6M
|
Health Technology
|
| O: -1.47%
H: 0.22%
C: -0.83%
JNJ | News | $144.77 0.22% -0.01% 9.3M
|
Health Technology
|
| O: 0.1%
H: 0.0%
C: 0.0%
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: 0.09%
H: 0.0%
C: 0.0%
bleeding expected reach disorders treatment global market
Valo Health and Novo Nordisk to collaborate to discover and develop novel treatments for cardiometabolic diseases using human data and artificial intelligence
Published: 2023-09-25 (Crawled : 12:00) - globenewswire.com
NVO | News | $124.53 0.88% 0.0% 2.6M
|
Health Technology
|
| O: -0.44%
H: 0.33%
C: 0.25%
health
Global Oral Proteins and Peptides Market Valued at $1.57 Billion in 2022, Driven by Rising Demand for Oral Treatments
Published: 2023-09-12 (Crawled : 00:00) - prnewswire.com
AZNCF | $135.305 -4.19% 1.1K
|
Health Technology
|
| O: 0.89%
H: 0.37%
C: -2.49%
NVO | News | $124.53 0.88% 0.0% 2.6M
|
Health Technology
|
| O: -2.21%
H: 1.23%
C: 0.11%
AZN | $68.53 0.39% 0.39% 3.7M
|
Health Technology
|
| O: -0.22%
H: 0.33%
C: -1.1%
global market
Global Obesity Treatment Market Poised to Reach $26.44 Billion by 2028, Fueled by Rising Prevalence and Innovative Interventions
Published: 2023-08-25 (Crawled : 02:00) - prnewswire.com
PFE A | $25.42 -1.05% -0.04% 44M
|
Health Technology
|
| O: -0.06%
H: 1.52%
C: 0.66%
NVO | News | $124.53 0.88% 0.0% 2.6M
|
Health Technology
|
| O: -0.34%
H: 1.29%
C: 0.93%
MDT | News | $79.08 -0.22% 0.0% 5.5M
|
Health Technology
|
| O: -0.98%
H: 1.19%
C: 0.82%
JNJ | News | $144.77 0.22% -0.01% 9.3M
|
Health Technology
|
| O: 0.51%
H: 0.0%
C: 0.0%
ABBV | $164.25 1.05% -0.76% 4M
|
Health Technology
|
| O: -0.11%
H: 0.44%
C: -0.22%
obesity reach treatment global market
Zealand Pharma Submits Marketing Authorization Application for Dasiglucagon for Treatment of Severe Hypoglycemia in Diabetes to the European Medicines Agency
Published: 2023-06-26 (Crawled : 07:00) - globenewswire.com
NVO | News | $124.53 0.88% 0.0% 2.6M
|
Health Technology
|
| O: 0.25%
H: 0.29%
C: -1.41%
pharma authorization treatment hypoglycemia application diabetes
Novo Nordisk A/S: Oral semaglutide 50 mg achieved 15.1% weight loss (17.4% if all people adhered to treatment) in adults with obesity or overweight in the OASIS 1 trial
Published: 2023-05-22 (Crawled : 15:00) - globenewswire.com
NVO | News | $124.53 0.88% 0.0% 2.6M
|
Health Technology
|
| O: -0.04%
H: 0.86%
C: 0.02%
obesity trial
Worldwide Recombinant Protein Industry to 2027: Elevating Prevalence of Several Chronic Diseases Along With the Increasing Demand for Novel Treatment Options Drives Growth
Published: 2023-02-23 (Crawled : 23:00) - prnewswire.com
SNYNF | News | $92.116 -2.18% 2.3K
|
Health Technology
|
| O: -2.11%
H: 0.0%
C: 0.0%
NVO | News | $124.53 0.88% 0.0% 2.6M
|
Health Technology
|
| O: -1.0%
H: 0.22%
C: 0.1%
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: 0.72%
H: 0.0%
C: 0.0%
TECH | $62.7 -2.05% -2.09% 900K
|
Health Technology
|
| O: -1.43%
H: 0.25%
C: -1.0%
AMGN | $264.07 -0.59% -0.59% 2.2M
|
Health Technology
|
| O: -0.33%
H: 0.1%
C: -1.34%
ABCM | $23.99 0.0% 7.4M
|
Health Technology
|
| O: -0.14%
H: 0.98%
C: 0.0%
treatment growth
Global Bleeding Disorders Treatment Market Report 2022: Industry Trends, Share, Size, Growth, Opportunities and Forecasts 2021-2027
Published: 2023-01-19 (Crawled : 21:00) - prnewswire.com
SNYNF | News | $92.116 -2.18% 2.3K
|
Health Technology
|
| O: -2.08%
H: 0.0%
C: 0.0%
TAK | $13.15 -0.61% 0.0% 1.6M
|
Health Technology
|
| O: -0.19%
H: 0.8%
C: 0.62%
NVO | News | $124.53 0.88% 0.0% 2.6M
|
Health Technology
|
| O: -0.23%
H: 0.56%
C: 0.55%
JNJ | News | $144.77 0.22% -0.01% 9.3M
|
Health Technology
|
| O: 0.34%
H: 0.01%
C: -0.8%
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: -0.41%
H: 0.0%
C: 0.0%
treatment bleeding global report market
Global Type 2 Diabetes Treatment Market Outlook Report 2022-2023 & 2027: Patent Cliff, Oral Antidiabetics, and Growing Focus on Accessibility and Affordability of Medicine Bolsters Growth
Published: 2023-01-04 (Crawled : 23:00) - prnewswire.com
AZNCF | $135.305 -4.19% 1.1K
|
Health Technology
|
| O: -0.93%
H: 3.08%
C: 3.08%
NVO | News | $124.53 0.88% 0.0% 2.6M
|
Health Technology
|
| O: -0.89%
H: 1.18%
C: 0.52%
NVS | News | $93.08 -0.13% 0.86% 1.2M
|
Health Technology
|
| O: -0.85%
H: 0.2%
C: -0.29%
JNJ | News | $144.77 0.22% -0.01% 9.3M
|
Health Technology
|
| O: -0.62%
H: 0.54%
C: -0.12%
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: -3.07%
H: 0.0%
C: 0.0%
AZN | $68.53 0.39% 0.39% 3.7M
|
Health Technology
|
| O: -0.49%
H: 1.65%
C: 0.94%
treatment patent global report growing diabetes growth market
iECURE Raises $65 Million to Advance In Vivo Gene Editing Programs for the Treatment of Rare Pediatric Liver Diseases
Published: 2022-11-30 (Crawled : 14:00) - biospace.com/
NVO | News | $124.53 0.88% 0.0% 2.6M
|
Health Technology
|
| O: 2.1%
H: 0.56%
C: 0.56%
DTIL | $11.5 -10.65% -11.91% 220K
|
Health Technology
|
| O: 1.54%
H: 4.55%
C: 3.79%
treatment rare liver
Global Bleeding Disorders Treatment Market Report 2022: Healthy Growth Expected Driven By Key Players Bayer, Pfizer, Octapharma & Others
Published: 2022-09-16 (Crawled : 16:00) - prnewswire.com
SNYNF | News | $92.116 -2.18% 2.3K
|
Health Technology
|
| O: 0.74%
H: 0.91%
C: -0.74%
NVO | News | $124.53 0.88% 0.0% 2.6M
|
Health Technology
|
| O: -1.76%
H: 0.55%
C: 0.03%
NVS | News | $93.08 -0.13% 0.86% 1.2M
|
Health Technology
|
| O: 0.1%
H: 0.25%
C: -0.21%
LLY | News | $750.77 0.54% -0.04% 3.1M
|
Health Technology
|
| O: -0.48%
H: 1.3%
C: 0.3%
BAX | News | $39.52 -0.13% 0.0% 2.8M
|
Health Technology
|
| O: -0.41%
H: 0.16%
C: -0.94%
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: -0.52%
H: 0.0%
C: 0.0%
AMGN | $264.07 -0.59% -0.59% 2.2M
|
Health Technology
|
| O: -0.34%
H: 2.35%
C: 1.87%
treatment bleeding global report expected growth market
Menopausal Hot Flashes Treatment Market Estimated to Rise at CAGR of 6% from 2019 to 2027, TMR Study
Published: 2022-08-25 (Crawled : 14:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: 0.03%
H: 0.0%
C: -1.29%
PFE A | $25.42 -1.05% -0.04% 44M
|
Health Technology
|
| O: 0.19%
H: 0.9%
C: 0.8%
NVO | News | $124.53 0.88% 0.0% 2.6M
|
Health Technology
|
| O: -0.18%
H: 1.45%
C: 1.44%
NVS | News | $93.08 -0.13% 0.86% 1.2M
|
Health Technology
|
| O: -0.28%
H: 0.13%
C: 0.04%
GSK | $39.6 -0.88% 0.0% 2.8M
|
Health Technology
|
| O: 0.0%
H: 0.63%
C: 0.6%
treatment study market
Global Acquired von Willebrand Disease (AvWD) Treatment Market Report 2022-2030 Featuring Key Players - Novo Nordisk A/S, Genentech, Inc., F. Hoffman-La Roche AG, Sanofi SA
Published: 2022-07-25 (Crawled : 14:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
NVO | News | $124.53 0.88% 0.0% 2.6M
|
Health Technology
|
| O: 0.83%
H: 0.67%
C: 0.32%
GSK | $39.6 -0.88% 0.0% 2.8M
|
Health Technology
|
| O: 0.76%
H: 0.19%
C: -1.06%
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: 2.0%
H: 0.0%
C: 0.0%
treatment global disease report roche acquired sanofi market
Novo Nordisk A/S: Mim8 phase 1 & 2 data demonstrates potential as once monthly treatment for people with haemophilia A
Published: 2022-07-11 (Crawled : 14:00) - globenewswire.com
NVO | News | $124.53 0.88% 0.0% 2.6M
|
Health Technology
|
| O: 1.18%
H: 1.24%
C: 0.45%
treatment haemophilia potential phase 1
Hemophilia Treatment Market to Reach $26.9 Bn, Globally, by 2031 at 7.5% CAGR: Allied Market Research
Published: 2022-07-05 (Crawled : 00:00) - prnewswire.com
NVO | News | $124.53 0.88% 0.0% 2.6M
|
Health Technology
|
| O: 0.28%
H: 1.67%
C: 1.13%
treatment research market
Gainers vs Losers
| 56% | 44% |
Top 10 Gainers
INVO | $1.76 131.58% 56.82% 230M
|
Health Technology
SINT | $0.0365 59.39% 37.26% 470M
|
Health Technology
WISA 4 | $9.19 50.66% 33.7% 65M
|
Electronic Technology
EDBL | News | $6.73 47.91% 32.39% 13M
|
GCTK | $0.715 36.27% 26.62% 640K
|
Manufacturing
TCON | $2.33 36.26% 26.61% 2M
|
Health Technology
TIRX | $0.48 6.43% 24.58% 4.8M
|
KZIA | $0.38 30.58% 23.42% 300K
|
Health Technology
VNDA | News | $5.23 29.14% 22.56% 24M
|
Health Technology
ATNF | $1.91 29.05% 22.51% 310K
|
Your saved searches
Save your searches and get alerts when important news are released.